__timestamp | Sarepta Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
---|---|---|
Wednesday, January 1, 2014 | 9757000 | 20272000000 |
Thursday, January 1, 2015 | 1253000 | 19652000000 |
Friday, January 1, 2016 | 5421000 | 21903000000 |
Sunday, January 1, 2017 | 154584000 | 22385000000 |
Monday, January 1, 2018 | 301034000 | 18854000000 |
Tuesday, January 1, 2019 | 380833000 | 16887000000 |
Wednesday, January 1, 2020 | 540099000 | 16658000000 |
Friday, January 1, 2021 | 701887000 | 15878000000 |
Saturday, January 1, 2022 | 933013000 | 14925000000 |
Sunday, January 1, 2023 | 1243336000 | 15846000000 |
Monday, January 1, 2024 | 16544000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, revenue trends offer a glimpse into the strategic maneuvers of key players. Teva Pharmaceutical Industries Limited, a giant in the generic drug market, has seen its revenue fluctuate over the past decade. From 2014 to 2023, Teva's revenue peaked in 2017, reaching approximately $22 billion, before experiencing a gradual decline to around $15.8 billion in 2023. This represents a 29% decrease, highlighting challenges in maintaining market dominance.
Conversely, Sarepta Therapeutics, Inc., a leader in genetic medicine, has demonstrated impressive growth. Starting with a modest revenue of under $10 million in 2014, Sarepta's revenue surged to over $1.2 billion by 2023, marking an exponential increase of over 12,000%. This growth underscores Sarepta's successful innovation and market expansion strategies. The contrasting trajectories of these companies reflect broader industry trends and strategic shifts.
Revenue Insights: Pfizer Inc. and Sarepta Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Zoetis Inc. or Teva Pharmaceutical Industries Limited?
Who Generates More Revenue? GSK plc or Teva Pharmaceutical Industries Limited
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Sarepta Therapeutics, Inc.?
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited or Jazz Pharmaceuticals plc: Who Leads in Yearly Revenue?
Teva Pharmaceutical Industries Limited vs MiMedx Group, Inc.: Examining Key Revenue Metrics
Revenue Insights: Genmab A/S and Sarepta Therapeutics, Inc. Performance Compared
Sarepta Therapeutics, Inc. or ADMA Biologics, Inc.: Who Leads in Yearly Revenue?
Revenue Showdown: Sarepta Therapeutics, Inc. vs Perrigo Company plc
Annual Revenue Comparison: Sarepta Therapeutics, Inc. vs Vericel Corporation
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.